Series A - Kanvas Biosciences

Series A - Kanvas Biosciences

Investment Firm

Overview

Mapping interactions foundational to therapeutic discovery and human health.

Announced Date

Jul 01, 2024

Funding Type

Series A

Highlights

Location

United States, North America

Social

Investor Lead

DCVC

DCVC

DCVC is a early_stage_venture and late_stage_venture and seed and venture firm.

Participant Investors

3

Investor Name
Participant InvestorFemHealth Ventures
Participant InvestorPangaea Ventures
Participant InvestorDCVC

Round Details and Background

Kanvas Biosciences raised $12500000 on 2024-07-01 in Series A

Mapping interactions foundational to therapeutic discovery and human health.

Company Funding History

3

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jun 22, 2023
Seed Round - Kanvas Biosciences
5-12.0M
Mar 18, 2024
Seed Round - Kanvas Biosciences
-3.9M
Jul 01, 2024
Series A - Kanvas Biosciences
6-12.5M

Recent Activity

There is no recent news or activity for this profile.